Chiesi Australia

Chiesi Australia company information, Employees & Contact Information

Explore related pages

Related company profiles:

Chiesi Australia PTY LTD is the Australia-New Zealand Division of Chiesi Farmaceutici S.p.A, a global pharmaceutical company based in Parma, Italy. Chiesi Farmaceutici S.p.A acquired Emerge Health in November 2019 to form Chiesi Australia Pty Ltd. Chiesi Australia Pty Ltd has a workforce over 90 people employed directly or indirectly with chosen partners, who are based out of our head office in Melbourne and across Australia as part of our experienced field-based sales teams.

Company Details

Employees
58
Founded
-
Address
500 Bourke St, Level 7,australia
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Melbourne, Victoria
Looking for a particular Chiesi Australia employee's phone or email?

Chiesi Australia Questions

News

Chiesi Global Rare Diseases Announces Multiple Presentations at 21st Annual WORLDSymposium™ Research Meeting - PR Newswire

Chiesi Global Rare Diseases Announces Multiple Presentations at 21st Annual WORLDSymposium™ Research Meeting PR Newswire

Chiesi Farmaceutici and Samay Announce Collaboration to Advance Early Detection of Small Airway Disease - ACCESS Newswire

Chiesi Farmaceutici and Samay Announce Collaboration to Advance Early Detection of Small Airway Disease ACCESS Newswire

Optimizing the CHF6523 Isocoumarin Core Scaffold: From the Preclinical Stage to Large-Scale Production - ACS Publications

Optimizing the CHF6523 Isocoumarin Core Scaffold: From the Preclinical Stage to Large-Scale Production ACS Publications

National Safe Work Month 2025: Online WHS system a winner for Chiesi Australia - Australian Industry Group

National Safe Work Month 2025: Online WHS system a winner for Chiesi Australia Australian Industry Group

Chiesi: Industry-leading respiratory health, rare diseases, and speciality care solutions - Innovation News Network

Chiesi: Industry-leading respiratory health, rare diseases, and speciality care solutions Innovation News Network

Chiesi Group announces performance growth in 2020 - GlobeNewswire

Chiesi Group announces performance growth in 2020 GlobeNewswire

Chiesi Group and Oak Hill Bio announce License and Development Agreement to develop, manufacture, and commercialize OHB-607, a potentially transformative neonatal therapy - Business Wire

Chiesi Group and Oak Hill Bio announce License and Development Agreement to develop, manufacture, and commercialize OHB-607, a potentially transformative neonatal therapy Business Wire

Chiesi Group Announces Establishment of New Global Rare Diseases Division - PR Newswire

Chiesi Group Announces Establishment of New Global Rare Diseases Division PR Newswire

Chiesi publishes its annual report: Group generates almost €2 billion and obtains B Corp certification in 2019 - GlobeNewswire

Chiesi publishes its annual report: Group generates almost €2 billion and obtains B Corp certification in 2019 GlobeNewswire

Bioasis and Chiesi Group Announce Rare Diseases Strategic Alliance - Business Wire

Bioasis and Chiesi Group Announce Rare Diseases Strategic Alliance Business Wire

Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc - GlobeNewswire

Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc GlobeNewswire

Top Chiesi Australia Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant